Jean Pierre Marolleau

Author

Also Known As

J P Marolleau, J. Marolleau, J. P. Marolleau, J.-P. Marolleau, J.P. Marolleau, JEAN PIERRE MAROLLEAU, Jean P. Marolleau, Jean Pierre Marolleau, Jean pierre Marolleau, Marolleau, Jean Pierre

130

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Hôpital Saint-Louis Centre Hospitalier Universitaire Amiens-Picardie Assistance Publique – Hôpitaux de Paris Inserm Sorbonne Université

About

Jean Pierre Marolleau is an author at Hôpital Saint-Louis specializing in medicine, hematology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	371
2	Health Sciences	3	3	116
3	Public Health	2	2	89
4	Blood Transplantation	2	2	61
5	Cell Biology	1	1	19

Jean Pierre Marolleau

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma T. Lamy, Gandhi Damaj, Pierre Soubeyran, Blood	2017	172
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study Dominique Farge, Jean Pierre Marolleau, Sarah Zohar, British Journal of Haematology	2002	136
Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: a Phase I/Iia Clinical Study Sophie Périé, Capucine Trollet, Vincent Mouly, Molecular Therapy	2013	133
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis Dominique Farge, Corneliu Hénégar, Maryvonnick Carmagnat, Arthritis & Rheumatism	2005	124
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome Bruno Royer, Stéphane Minvielle, Momar Diouf, Journal of Clinical Oncology	2016	105
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, American Journal of Hematology	2013	100
Placebo-Controlled phase III Study of lenograstim (Glycosylated recombinant human granulocyte colony-Stimulating factor) in Aggressive non-Hodgkin's lymphoma: Factors influencing chemotherapy administration Christian Gisselbrecht, Corinne Haïoun, Éric Lepage, Leukemia & lymphoma/Leukemia and lymphoma	1997	90
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study Pieternella J. Lugtenburg, Irit Avivi, Henriette W Berenschot, Haematologica	2017	73
Efficacy of lenalidomide in <scp>POEMS</scp> syndrome: A retrospective study of 20 patients Bruno Royer, Lavinia Merlusca, Julie Abraham, American Journal of Hematology Retrospective StudyClinical DisordersPeripheral EdemaPoems SyndromePsychiatry	2012	67
Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas Patricia Franchi-Rezgui, Philippe Rousselot, Marc Espié, The Hematology Journal Non-hodgkin LymphomasLymphoid NeoplasiaInfertilityFertilityReproductive Health	2003	67

Page 1